Pediatrix Medical Group, Inc.

NYSE:MD 株式レポート

時価総額:US$620.9m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Pediatrix Medical Group バランスシートの健全性

財務の健全性 基準チェック /26

Pediatrix Medical Groupの総株主資本は$856.2M 、総負債は$709.8Mで、負債比率は82.9%となります。総資産と総負債はそれぞれ$2.2Bと$1.3Bです。 Pediatrix Medical Groupの EBIT は$152.2Mで、利息カバレッジ比率4.2です。現金および短期投資は$115.5Mです。

主要情報

82.9%

負債資本比率

US$709.76m

負債

インタレスト・カバレッジ・レシオ4.2x
現金US$115.47m
エクイティUS$856.20m
負債合計US$1.31b
総資産US$2.17b

財務の健全性に関する最新情報

Recent updates

Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger

May 10
Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger

Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking

Mar 29
Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking

Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price

Jan 10
Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price

Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors

Dec 25
Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors

Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Nov 14
Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?

Oct 13
Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?

Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Aug 09
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold

Aug 08

At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?

Jul 03
At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?

The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing

Jun 08
The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing

Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet

Apr 26
Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet

Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?

Feb 20
Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?

Pediatrix Medical Group Q4 2022 Earnings Preview

Feb 16

Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Jan 12
Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold

Dec 22

Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing

Dec 20
Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing

Pediatrix appoints James Swift as chief executive officer

Dec 15

Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Nov 05
Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M

Nov 03

Pediatrix: These 5 Graphs Suggest It's A Buy

Sep 29

Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly

Sep 13
Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly

Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return

Aug 29
Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return

Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Jul 27
Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Pediatrix: Seeking 46% Return Objective As Speculative Buy

Jul 14

MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jun 24
MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate

MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet

May 25
MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet

Return Trends At MEDNAX (NYSE:MD) Aren't Appealing

Apr 20
Return Trends At MEDNAX (NYSE:MD) Aren't Appealing

MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price

Mar 08
MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price

MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly

Feb 15
MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly

Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital

Jan 19
Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital

Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?

Nov 17
Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?

These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well

Oct 23
These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well

Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital

Oct 08
Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital

Is MEDNAX (NYSE:MD) A Risky Investment?

Jul 19
Is MEDNAX (NYSE:MD) A Risky Investment?

MEDNAX (NYSE:MD) Could Be Struggling To Allocate Capital

Jun 27
MEDNAX (NYSE:MD) Could Be Struggling To Allocate Capital

Statutory Profit Doesn't Reflect How Good MEDNAX's (NYSE:MD) Earnings Are

May 15
Statutory Profit Doesn't Reflect How Good MEDNAX's (NYSE:MD) Earnings Are

Mednax Q1 2021 Earnings Preview

May 06

Does MEDNAX (NYSE:MD) Have A Healthy Balance Sheet?

Mar 14
Does MEDNAX (NYSE:MD) Have A Healthy Balance Sheet?

財務状況分析

短期負債: MDの 短期資産 ( $426.5M ) が 短期負債 ( $247.3M ) を超えています。

長期負債: MDの短期資産 ( $426.5M ) は 長期負債 ( $1.1B ) をカバーしていません。


デット・ツー・エクイティの歴史と分析

負債レベル: MDの 純負債対資本比率 ( 69.4% ) は 高い と見なされます。

負債の削減: MDの負債対資本比率は、過去 5 年間で76.2%から82.9%に増加しました。

債務返済能力: MDの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 15.9% )。

インタレストカバレッジ: MDの負債に対する 利息支払いEBIT ( 4.2 x coverage) によって 十分にカバーされています


貸借対照表


健全な企業の発掘